An infant has undergone a personalized gene-editing treatment, reportedly becoming the world's first patient to receive such therapy. The treatment, which used CRISPR gene editing, was performed for a rare genetic disease, although there is uncertainty about the location, with one report indicating it occurred in Israel and others suggesting involvement of the Children's Hospital of Philadelphia. The outcome of the treatment appears to be positive, with the child showing signs of improvement, such as taking first steps.